Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease

Joint Bone Spine

Volumn 80, Issue 6, 2013, Pages 653-655

  Banse, Christopher ^a   Vittecoq, Olivier ^a   Benhamou, Ygal ^b   Gauthier Prieur, Maud ^c   Lequerré, Thierry ^a   Lévesque, Hervé ^b  

^a INSERM   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c Hôpital d'Elbeuf   (France)

Author keywords

Canakinumab; Macrophage activation syndrome; Polyvalent immunoglobulins; Still's disease

Indexed keywords

CANAKINUMAB; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; FERRITIN; GLUCOCORTICOID; IMMUNOGLOBULIN; INFLIXIMAB; LACTATE DEHYDROGENASE; METHOTREXATE; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TOCILIZUMAB; ANTIRHEUMATIC AGENT; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ADULT; ADULT ONSET STILL DISEASE; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CUTANEOUS MELANOMA; CYTOLYSIS; DISEASE CONTROL; DRUG MEGADOSE; DYSPNEA; ERYTHROPHAGOCYTOSIS; FEMALE; FERRITIN BLOOD LEVEL; FEVER; GRANULOMATOUS INFLAMMATION; HEPATOMEGALY; HUMAN; HYPERFERRITINEMIA; HYPERTRIGLYCERIDEMIA; IMMUNOTHERAPY; INJECTION; KIDNEY FAILURE; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTOSIS; LOW BACK PAIN; LYMPHADENOPATHY; MACROPHAGE ACTIVATION SYNDROME; MEDIASTINUM; MEDIASTINUM LYMPH NODE; MEDICAL HISTORY; MELANOMA; NEUTROPHIL COUNT; ODYNOPHAGIA; PHAGOCYTOSIS; PHARYNGITIS; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PROXIMAL INTERPHALANGEAL JOINT; RASH; SARCOIDOSIS; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TONIC CLONIC SEIZURE; TONSILLITIS; URINE CULTURE; WEIGHT REDUCTION; ANTAGONISTS AND INHIBITORS; COMPLICATION; MIDDLE AGED; STILL'S DISEASE, ADULT-ONSET;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; INTERLEUKIN-1BETA; MACROPHAGE ACTIVATION SYNDROME; MIDDLE AGED; STILL'S DISEASE, ADULT-ONSET;

EID: 84888440212     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2013.04.011     Document Type: Article

References (13)

1. Arlet J.B., Le Thi Huong D.B., Pouchot J., et al. Current concepts on the physiopathology of adult-onset Still's disease. Rev Med Interne 2005, 26:549-556. [In French].
2. Yamaguchi M., Ohta A., Tsunematsu T., et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992, 19:424-430.
3. Fautrel B., Zinc E., Golmard J.L., et al. Proposal for a new set of classification criteria for adult-onset Still disease. Medicine 2002, 81:194-200.
4. Kontzias A., Efthimiou P. The use of Canakinumab, a novel IL- 1β long-acting inhibitor, in refractory adult-onset Still's disease. Semin Arthritis Rheum 2012, 42:201.
5. Grom A.A. Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?. Arthritis Rheum 2004, 50:689-698.
6. Arlet J.B., Le T.H., Marinho A., et al. Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature. Ann Rheum Dis 2006, 65:1596-1601.
7. Dhote R., Simon J., Papo T., et al. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum 2003, 15:633-639.
8. Fukaya S., Yasuda S., Hashimoto T., et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology 2008, 47:1686-1691.
9. Emmenegger U., Frey U., Reimers A., et al. Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndrome. Am J Hematol 2001, 68:4-10.
10. Gattorno M., Piccini A., Lasiglie D., et al. The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2008, 58:1505-1515.
11. Kobayashi M., Takahashi Y., Yamashita H., et al. Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome. Mod Rheumatol 2011, 21:92-96.
12. Li J., Uetrecht J.P. D-penicillamine-induced autoimmunity: relationship to macrophage activation. Chem Res Toxicol 2009, 22:1526-1533.
13. Stephan J.L., Kone-Paut I., Galambrun C., et al. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology 2001, 40:1285-1292.